第一作者:
Aikou,Okamoto
第一单位:
*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto, Canada.
作者:
医学主题词
腺癌, 透明细胞(Adenocarcinoma, Clear Cell);综合疗法(Combined Modality Therapy);女(雌)性(Female);人类(Humans);医学肿瘤学(Medical Oncology);卵巢肿瘤(Ovarian Neoplasms);诊疗准则(主题)(Practice Guidelines as Topic);学会, 医学(Societies, Medical)
DOI
10.1097/IGC.0000000000000289
PMID
25341576
发布时间
2026-01-20
- 浏览36
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



